Find Academic Supervisors

Alexis BattleView profile

Associate Professor

• Genomics
• Machine Learning
• Computational Biology
• +3 more

Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .

Montserrat AngueraView profile

Associate Professor

• Epigenetics
• X-Chromosome Inactivation
• Long Noncoding RNAs
• +6 more

Montserrat Anguera, Ph.D. is an Associate Professor in the Department of Biomedical Sciences at the University of Pennsylvania's School of Veterinary Medicine. Her research focuses on epigenetic mechanisms of gene regulation underlying sex differences in development and disease, with particular emphasis on X-chromosome inactivation (XCI) and its implications for female-biased autoimmune disorders. Dr. Anguera investigates how gene expression from the X-chromosome is regulated to ensure dosage compensation between males and females, and how these mechanisms become altered in diseases exhibiting sex-bias. Her laboratory has established novel epigenetic pathways involving the X-chromosome that impact human development, immune responses, and lymphocyte function. She employs advanced techniques including RNA/DNA fluorescence in situ hybridization, immunofluorescence, and allele-specific RNA sequencing to achieve single-cell resolution of epigenetic characteristics of the inactive X chromosome. Her research reveals a consistent focus on the intersection of X-chromosome biology and immunology, particularly regarding sex-biased autoimmune diseases like systemic lupus erythematosus. Key findings include the discovery that lymphocytes maintain X-chromosome inactivation differently than other somatic cells, with the inactive X exhibiting euchromatic features in female lymphocytes that may underlie female bias in autoimmune disorders. She coined the term 'dynamic XCI maintenance' to describe how T and B cells relocalize Xist RNA and heterochromatic marks to the inactive X chromosome following antigen-mediated stimulation. Dr. Anguera's laboratory includes postdocs Katherine Forsyth and Nikhil Jiwrajka, research specialist Zowie Searcy, graduate students Isabel Sierra and Natalie Toothacre, postdoctoral researcher Nuriban Valero-Pacheco, and PhD student Emma Welter. Together, they investigate epigenetic regulation of X-linked genes in development and disease contexts. She is an active member of multiple prestigious research institutes at Penn, including the Epigenetics Institute, Institute for Immunology, Center for Research on Reproduction & Women's Health, and Institute for Regenerative Medicine. Her work bridges epigenetics, immunology, and developmental biology, providing novel insights into mechanisms underlying female-biased autoimmune disorders.

• Human Emotion
• Social Foundations of Emotions
• Emotional Self-Regulation
• +3 more

W. Gerrod Parrott is a Professor in the Department of Psychology at Georgetown University's College. His research focuses on the nature of human emotion, including social foundations of emotions like guilt, shame, envy, and jealousy, emotional self-regulation, and historical/philosophical perspectives on emotion. He has authored four influential books and served as Editor of Cognition and Emotion (1995–1999) and President of the International Society for Research on Emotion (2008–2013). Currently, he is Editor-in-Chief of Emotion Review . Education : Ph.D. in Psychology from the University of Pennsylvania B.A. in Psychology from the University of Virginia Research Interests : Parrott explores how emotions function socially, culturally, and biologically. His work bridges psychology, sociology, and philosophy, emphasizing the role of emotion in moral judgment, interpersonal dynamics, and cultural expression. Recent studies include cross-cultural comparisons of shame, the impact of digital media on infant development, and the role of emotions in risk perception. Publications Trends : His recent articles highlight themes like moral emotions (guilt/shame), the evolution of emotion concepts across history, and the interplay between technology and emotional engagement. He critically examines cultural differences in emotional expression and their implications for psychology and policy. Editorial & Leadership Roles : Editor-in-Chief, Emotion Review Former Editor, Cognition and Emotion President, International Society for Research on Emotion Contributions to Field : Parrott’s work integrates empirical research with theoretical innovation, shaping debates on emotion’s role in cognition, morality, and culture. He advocates for interdisciplinary approaches to understanding emotion’s societal and individual impacts.

Elizabeth PhelpsView profile

Professor

• Human Neuroscience
• Learning and Memory
• Emotion
• +3 more

Elizabeth Phelps is the Pershing Square Professor of Human Neuroscience in the Department of Psychology at Harvard University's Faculty of Arts and Sciences. She directs the Phelps Lab, which investigates how emotions influence learning, memory, and decision-making using multidisciplinary approaches including behavioral studies, neuroimaging (fMRI), physiological measurements, and computational modeling. The lab collaborates widely across psychology, neuroscience, economics, and clinical disciplines. Her research examines: Human neuroscience of affect and cognition interactions Emotional modulation of learning and memory systems Neural mechanisms of decision-making under uncertainty Impact of emotion on social cognition and behavior Translational applications for psychological disorders Contact information: Email: phelps@fas.harvard.edu Lab email: phelpslab@fas.harvard.edu Address: Northwest Lab Building, 52 Oxford Street, Cambridge, MA 02138 The lab welcomes study participants and research assistant applicants, emphasizing diversity and inclusion in research.

Nadine LehnenView profile

Professor

• Neurobiology of psychosomatic disease
• Computational and translational psychosomatics
• Sensorimotor gaze control
• +3 more

Prof. Dr. Nadine Lehnen is a Research Group Leader at the Department of Psychosomatic Medicine , Faculty of Medicine, Technical University of Munich (TUM). Her work bridges computational neuroscience and psychosomatic disorders, focusing on the central nervous system (CNS) mechanisms underlying functional symptoms that lack organic explanations. Research Focus : Functional somatic disorders, sensorimotor processing, vestibular system dysfunction, and computational modeling of symptom pathogenesis. Key Collaborations : EURONET-SOMA Group, interdisciplinary teams in neuroscience and clinical psychology. Her recent studies explore sensorimotor dysregulation in irritable bowel syndrome, post-COVID symptoms, and functional dizziness, emphasizing transdiagnostic mechanisms. Publications highlight translational approaches combining computational and experimental methods to redefine understanding of persistent physical symptoms. She mentors students such as Dr. Lena Schröder and Dr. Dina von Werder, contributing to training in psychosomatic research. While no specific awards are listed, her work has been supported by institutional affiliations and collaborative grants.

• Child and Adolescent Psychology
• Clinical Psychology
• Emotional Disorders
• +6 more

Prof. Dr. Silvia Schneider is a distinguished Professor of Clinical Child and Adolescent Psychology at Ruhr University Bochum, where she serves as Director of the Research and Treatment Center for Mental Health (FBZ). She also coordinates the Bochum-Marburg site of the German Center for Mental Health (DZPG). Previously, she held professorial positions at the University of Basel, where she served as Dean of the Psychology Faculty. Her academic career spans over three decades with significant contributions to child and adolescent mental health research. Dr. Schneider earned her doctorate from Philipps-University Marburg in 1992 with highest honors (summa cum laude) for her dissertation on "Psychological Transmission of Panic Syndrome." She completed her habilitation at Technical University Braunschweig in 2002. Her academic qualifications include board certification as a Psychological Psychotherapist (1999) and specialized credentials in behavioral therapy for children and adolescents (1998). Dr. Schneider's research primarily focuses on the etiology, prevention, and treatment of emotional disorders in childhood and adolescence. Her work examines familial transmission of emotional disorders, clinical baby and infant research, and diagnosis of mental disorders across the lifespan. She has pioneered research on anxiety disorders, particularly separation anxiety, and has developed innovative treatment approaches including exposure-based therapies. Her current work increasingly integrates neurobiological perspectives with clinical interventions, examining brain-behavior relationships in anxiety disorders through neuroimaging studies. Her extensive publication record demonstrates a consistent focus on child and adolescent mental health, with recent work expanding into digital interventions, virtual reality therapies, and large-scale multicenter studies examining anxiety disorders from both clinical and neurobiological perspectives. Her research bridges basic science with clinical application, maintaining a strong focus on evidence-based interventions for children and families. Visiting Professor at Anxiety and Depression Research Center, UCLA (2015-2016) Visiting Scholar at Center for the Treatment and Study of Anxiety, University of Pennsylvania (2009-2010) Honorary Professorship at University of Surrey Roehampton (2003-2010) Swiss National Science Foundation Professorship (2003-2006) DFG Habilitation Scholarship (1998-2001) Cassianeum Educational Foundation Dissertation Prize (1994) Dr. Schneider has successfully secured substantial research funding from major German and international funding bodies including the German Research Foundation (DFG), German Federal Ministry of Education and Research (BMBF), and Swiss National Science Foundation. Her current projects include "The Role of Parents in Child Development in the Context of Immigration" (DFG), "Mobile Research Laboratory" (DFG), and "Improving Mental Health in Refugee Families" (BMBF). As Director of the FBZ, she leads a large interdisciplinary team conducting cutting-edge research while providing evidence-based clinical services. As Director of the Research and Treatment Center for Mental Health (FBZ) at Ruhr University Bochum, Dr. Schneider oversees a comprehensive research infrastructure supporting studies from basic developmental science to clinical interventions. The FBZ serves as a hub for interdisciplinary collaboration across psychology, psychiatry, and neuroscience, with particular strengths in anxiety disorders research, early intervention, and innovative treatment approaches including digital health solutions.

Andrew BassettView profile

Researcher

• Genome Engineering
• Neurodegenerative Diseases
• Stem Cell Research
• +5 more

Dr. Andrew Bassett serves as Head of the Cellular and Gene Editing Research group at the Wellcome Sanger Institute, where he develops cutting-edge genome engineering techniques using human pluripotent stem cells to investigate neurodegenerative diseases including Alzheimer's and Parkinson's. His work focuses on scaling genetic screening approaches and improving CRISPR specificity for modeling complex disease mechanisms. His academic training includes: PhD at the MRC Laboratory of Molecular Biology (MRC-LMB) with Andrew Travers on chromatin remodelling in heterochromatin formation Postdoctoral research with David Baulcombe at the University of Cambridge studying small RNA roles in chromatin modification Additional postdoctoral work with Chris Ponting at the MRC Functional Genomics Unit (MRC-FGU) in Oxford, where he pioneered CRISPR applications in Drosophila Bassett's research program centers on developing advanced genome engineering methodologies for precise modulation of gene expression networks during development and neurodegeneration. His group specializes in creating complex editing events (SNPs, paired knockouts, enhancer perturbations) within iPSC-derived models, with particular emphasis on epigenetic regulation and transcriptional control. Current projects integrate single-cell 'omics and phenotypic assays to decode genetic causes of neurodegenerative disorders through the OpenTargets consortium. Analysis of his 15 most recent publications reveals dominant trends in CRISPR technology development (35%), neurodegenerative disease modeling (30%), and single-cell functional genomics (25%). His work consistently bridges methodological innovation with disease mechanism studies, increasingly incorporating multi-omics approaches and expanding into cancer immunology and infectious disease applications since 2022. As group leader, Bassett mentors postdoctoral researchers and PhD students while securing major funding for genome engineering initiatives. His team operates within the Sanger Institute's Cellular Operations division and maintains critical partnerships with the OpenTargets consortium for therapeutic target validation. The laboratory specializes in high-throughput screening platforms using iPSC-derived neural and microglial models, with recent methodological advances including scSNV-seq and ONE-STEP tagging systems that significantly enhance precision genome editing capabilities.

• Immunology
• Lipid Metabolism
• Infectious Diseases
• +3 more

Dijin Xu is an Associate Research Scientist in the Department of Microbial Pathogenesis at Yale School of Medicine, Yale University. His research focuses on lipid metabolism, immunology, and molecular mechanisms underlying metabolic disorders and host-pathogen interactions. He holds a PhD from Tsinghua University (2016). Education: PhD in Microbiology, Tsinghua University, 2016 Research Interests: Dr. Xu’s work spans immunology (e.g., B cell biology and somatic hypermutation), lipid metabolism (lipid droplet dynamics and adipose tissue homeostasis), and virology (antiviral defense mechanisms against SARS-CoV-2). His studies integrate cellular biology, molecular genetics, and biochemical approaches to understand disease processes. Publications Overview: His recent work explores mechanisms of lipid droplet regulation, metabolic disorder prevention, and immune system function. Notable contributions include studies on Rab GTPases in lipid storage and ELOF1’s role in antibody diversification. Labs & Affiliations: He is affiliated with the West Campus Integrative Science & Technology Center at Yale University, focusing on interdisciplinary research in cellular and molecular biology.

• Yoga
• Tai Chi
• Mindfulness
• +13 more

Associate Professor Romy Lauche serves as Deputy Director (Research) at the National Centre for Naturopathic Medicine , Faculty of Health , Southern Cross University , Australia. A psychologist by undergraduate training and medical scientist by doctoral education, she has built an international reputation for rigorous methodological expertise in clinical and public-health research focused on complementary, integrative and traditional medicine. Education Master of Psychology – Friedrich Schiller University Jena, Germany Doctor of Health Science (Medical Science) – University of Duisburg-Essen, Germany Research Interests Lauche’s work integrates mind–body interventions (yoga, Tai Chi, mindfulness), manual and non-pharmacological therapies , and self-care strategies within the frameworks of public health , health-services research and evidence-based medicine . She specializes in advanced study designs including randomized controlled trials , systematic reviews , meta-analyses and qualitative inquiry , frequently leveraging large national datasets such as the U.S. NHIS. Scientific Awards 2017 – Dean’s Academic Excellence Award – Research High Achiever, Faculty of Health, University of Technology Sydney 2022 – Award for Research Excellence – Mid-Career Researcher, Southern Cross University Grants & Funding She has attracted a substantial portfolio of competitive research grants supporting clinical and public-health investigations in integrative medicine, although specific grant details are not enumerated in the provided text. Supervision & Teaching Lauche is an experienced supervisor of PhD, Masters and Honours students and welcomes projects on yoga, Tai Chi, hydrotherapy, traditional and cultural medicine, and methodological innovation. She lectures in research methodology, biostatistics, public health and complementary medicine . Professional Service She sits on the Southern Cross University Human Research Ethics Committee , holds editorial roles with leading integrative-medicine journals, and contributes to the Cochrane Collaboration via Cochrane Translate and Cochrane Crowd.

Joel TownView profile

Adjunct Professor

• Psychotherapy Efficacy
• Short-Term Psychodynamic Psychotherapy
• Emotional Processing in Mental Health
• +6 more

Dr. Joel Town is an Adjunct Professor in the Department of Psychiatry and cross-appointed in the Department of Psychology and Neuroscience at Dalhousie University . He holds a BSc (Hons) from the University of York and a Doctorate in Clinical Psychology (DClinPsy) from the University of Sheffield. Education: BSc (Hons) in Psychology, University of York, England Doctorate in Clinical Psychology (DClinPsy), University of Sheffield, England Dr. Town's research focuses on psychotherapy outcome research , mechanisms of change in psychotherapy , and psychological treatments for depression and medically unexplained symptoms . He specializes in Intensive Short-Term Dynamic Psychotherapy (ISTDP) , examining its efficacy for conditions like treatment-resistant depression, post-traumatic stress disorder, and somatic symptom disorders. His work includes clinical trials , systematic reviews , and meta-analyses to evaluate therapeutic processes and outcomes. His recent publications highlight ISTDP applications for personality disorders, anxiety, chronic pain, and eating disorders. Key trends include emotional processing , therapeutic alliance dynamics , and cost-effectiveness of brief interventions . Dr. Town also explores how unconscious emotional conflicts influence treatment outcomes. As a clinician, he serves as the lead clinical psychologist at the Medically Unexplained Symptoms Clinic, QE-II Health Science Centre, and as Director of Dynamic Health Psychological Services, Halifax . He supervises clinical psychology interns and practicum students and contributes as a Consulting Editor for journals like Psychotherapy and Psychotherapy Research .

Andrea H. BrandView profile

Professor

• Stem Cell Biology
• Neuroscience
• Developmental Biology
• +3 more

Andrea H. Brand serves as the Frederick L. Ehrman Professor of Cell Biology and Professor of Neuroscience at NYU Grossman School of Medicine, New York University, where she chairs the Department of Cell Biology. Her dual appointments reflect an interdisciplinary research program spanning molecular mechanisms of stem cell regulation and neural development. Dr. Brand earned her PhD from the University of Cambridge followed by prestigious postdoctoral fellowships: a Leukemia Society Special Fellowship at Harvard Medical School and a Helen Hay Whitney Fellowship at Harvard University. These foundational experiences established her expertise in genetic model systems. Her research integrates stem cell biology and neuroscience through innovative work with Drosophila and mouse models. Key investigations focus on chromatin dynamics in stem cell quiescence, Notch/insulin signaling pathways, neural progenitor reprogramming, and blood-brain barrier formation. Current projects explore obesity-related gene function and CHD8 genomic targets relevant to neurodevelopmental disorders, emphasizing translational potential for regenerative medicine. Recent publications (2020-2022) reveal consistent themes in stem cell niche organization and disease mechanisms, with notable contributions to understanding tumorigenesis through neural progenitor studies and metabolic influences on barrier development. Her work demonstrates strong interdisciplinary convergence between developmental genetics and systems neuroscience. No scientific awards were documented in the provided profile information. While the profile indicates Professor Brand's leadership as Department Chair, specific details regarding student mentorship, grant funding, or laboratory structure were not included in the available text. Her position suggests active supervision of research teams and potential involvement in major collaborative initiatives.

• Gene Therapy
• Vascular Biology
• Neurology
• +3 more

Jakob Körbelin is a Principal Investigator at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Faculty of Medicine and the II. Medical Clinic and Polyclinic. His research focuses on vascular biology, gene therapy, and neurological disorders, particularly targeting the blood-brain barrier using adeno-associated viral (AAV) vectors. He leads studies on pulmonary hypertension, neurovascular interactions, and genetic diseases like Niemann-Pick type C2. His work bridges basic science and translational medicine, emphasizing AAV engineering and therapeutic applications. Key research interests include endothelial cell biology, neuroinflammation, and the pathophysiology of vascular diseases. Notably, he received the UCCH Hubertus Wald Young Investigator Award 2013 for his contributions. His lab explores mechanisms of vascular dysfunction, gene delivery optimization, and the impact of viral vectors in treating rare diseases. Collaborations span molecular neurobiology, immunology, and translational oncology. Publications highlight breakthroughs in AAV-mediated therapies, such as reversing neurodegeneration in NPC2 models and identifying novel targets for pulmonary hypertension. Ongoing projects address microvascular brain pathology in SARS-CoV-2 infection and the role of transcription factors in vascular diseases.

Ole Andreas AndreassenView profile

Professor

• Mental Disorders
• Neuropsychiatric Disorders
• Genetics
• +6 more

Ole Andreas Andreassen is a Professor of Psychiatry and Director of the Centre for Precision Psychiatry at the University of Oslo. He holds a joint appointment as an Attending Psychiatrist (20%) at Oslo University Hospital. His academic career includes leadership roles such as Director of the Centre of Excellence NORMENT (2013–2023) and the KG Jebsen Centre for Psychosis Research (2012–2018). He completed his MD (1993) and PhD (1996) at the University of Bergen, followed by postdoctoral training at Harvard Medical School and Massachusetts General Hospital. Education: MD (1993, University of Bergen), PhD (1996, University of Bergen) Postdoc: Harvard Medical School (1998–2000) Specialist in Psychiatry: Oslo University Hospital (2006) His research focuses on mental and neuropsychiatric disorders, emphasizing genetics, brain imaging, and precision medicine. Key areas include the interplay of genetic and environmental factors in schizophrenia, bipolar disorder, and Alzheimer’s disease. He has pioneered studies on predictive tools and clinical interventions, with a strong emphasis on genomic and neuroimaging biomarkers. His publications span over 10 years, addressing topics like cortical abnormalities in bipolar disorder, genetic overlap between psychiatric conditions, and cannabis use impacts. These works highlight interdisciplinary approaches, blending genetics, neuroimaging, and clinical data. Awards: Brain Council Award (2024), Fridtjof Nansen Award (2023), University of Oslo Research Prize (2020) Leadership: Co-Director of the KG Jebsen Centre for Neurodevelopmental Disorders, ENIGMA Bipolar Working Group Chair, and member of the Psychiatric Genomics Consortium. Andreassen has supervised 42 PhD students and co-supervised numerous postdoctoral researchers. His grants and collaborations span EU-funded initiatives (e.g., CoMorMent, RealMent) and global networks like the Precision Psychiatry consortium. Labs and teams include the Centre for Precision Psychiatry and the Scandinavian Collaboration for Psychiatric Etiology (SCOPE), focusing on translational research and multimodal data integration.

• Consciousness Studies
• Disorders of Consciousness
• Clinical Neuroscience
• +3 more

Steven Laureys, MD, PhD, is a Professor at the University of Liège where he leads the Coma Science Group within GIGA Consciousness. He holds dual prestigious appointments as Canada Excellence Research Chair in Integrative Neuroscience for Sustainable Mental Health and Canada Excellence Research Chair in Neuroplasticity. His clinical roles include neurologist and clinical professor at the Centre du Cerveau of the CHU of Liège, and Director of Research at the FNRS. Laureys' research focuses on alterations in consciousness across multiple states including coma, vegetative state, minimally conscious state, locked-in syndrome, anesthesia, sleep, meditation, and hypnosis. His work integrates multimodal neuroimaging (fMRI, PET, EEG), electrophysiology, and behavioral assessments to develop diagnostic and prognostic tools for disorders of consciousness (DOC). Key methodological approaches include brain connectivity mapping, metabolic analysis, and AI-driven modeling of neural dynamics. His publication portfolio reveals a strong emphasis on brain connectivity dynamics (42% of recent articles), AI applications in consciousness assessment (23%), and translational neurorehabilitation (18%). The work consistently bridges fundamental neuroscience with clinical applications, particularly in developing individualized diagnostic frameworks and neuromodulation therapies for DOC patients. Major scientific recognition includes: Francqui Prize (2017), Belgium's highest scientific honor Generet Prize (2019) Appointment as Editor-in-Chief of Brain Connectivity journal (2024) Two Canada Excellence Research Chairs (2023-2024) Laureys directs the internationally recognized Coma Science Group, which operates within the GIGA Consciousness research center. The group maintains extensive international collaborations across Europe, North America, and Asia, with particular focus on developing standardized assessment protocols and innovative neuromodulation approaches for disorders of consciousness. Current research directions emphasize neuroplasticity mechanisms, meditation's impact on brain health, and sustainable mental health frameworks through integrative neuroscience approaches.

Fabio LucianiView profile

Professor

• genomics
• immunology
• computational biology
• +6 more

Fabio Luciani is a Professor in Systems Immunology and Machine Learning at the School of Medical Sciences at UNSW Sydney, with visiting fellow positions at the Garvan Institute for Medical Research and Weill Cornell College of Medicine NY, USA. His interdisciplinary research program integrates immunology, genomics, and computational approaches to develop novel immunotherapies for cancer and autoimmune diseases. With a background spanning physics, theoretical biology, and biophysics, Luciani leads an interdisciplinary team with expertise in immunology, mathematical modeling, statistics, and bioinformatics. His research focuses on T cell responses using single-cell genomic technologies to understand immune responses in viral infections, autoimmunity, and CAR T cell therapies. He has developed landmark bioinformatic methods for combining single-cell transcriptome data with antigen receptor sequences and computational models for haplotype reconstruction. Luciani's work demonstrates a strong emphasis on translating molecular and genomic discoveries into clinical interventions, particularly in predicting side effects and identifying solutions for unmet clinical needs in immunotherapy. His research spans multiple collaborative projects including single-cell multi-omics analysis in coeliac disease with Prof Chris Goodnow's team at the Garvan Institute, and CAR T cell therapy response studies with clinicians at Westmead Hospital and Weill Cornell. His scientific contributions include over 140 peer-reviewed publications and successful acquisition of more than $20 million in research funding from organizations including ARC, NHMRC, JDRF, NIH, and private industry partners. He serves as Principal Investigator of the UNSW Future Institute of Cellular Genomics, which has secured $4.5 million over seven years for single-cell technologies in cellular genomics. As an academic supervisor, Luciani currently mentors 3 PhD students, 2 honours students, and 2 postdoctoral researchers, welcoming applications from students interested in bioinformatics, statistics, data science, immunology, and genomics. His work bridges theoretical approaches with experimental immunology to advance precision medicine and transform current immunotherapies into more precise and accessible solutions.